Skip to content

Capricor Therapeutics CAPR Other Current Liabilities

Other Current Liabilities at other companies

Duke Energy logo
Duke EnergyDUK
-$468M-122%
Fluor logo
FluorFLR
$0
LKQ logo
LKQLKQ
$75M+500%
Keurig Dr Pepper logo
Keurig Dr PepperKDP
-$129M+25.4%
Silicon Laboratories logo
Silicon LaboratoriesSLAB
-$7.42M-162%
Citigroup logo
CitigroupC
$1.33B+35.9%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's other current liabilities?
Capricor Therapeutics (CAPR) reported other current liabilities of -$3.08M in Q1 2026.
How has Capricor Therapeutics's other current liabilities changed year-over-year?
Capricor Therapeutics's other current liabilities decreased by 334.3% year-over-year, from $1.32M to -$3.08M.